Medicine News and Research

RSS

Addition of family physicians linked to reduced risk of hospital readmissions

Researchers from Boston University School of Medicine and Boston Medical Center have found that by adding one family physician per 1,000, or 100 per 100,000, could reduce hospital readmission costs by $579 million per year, or 83 percent of the Patient Protection and Affordable Care Act target.

4 May 2011

Confusing research on salt and heart: Study

According to the latest European study, people who ate lots of salt were not more likely to get high blood pressure, and were less likely to die of heart disease than those with a low salt intake. This is contrary to what has been known till date. The U.S. guidelines recommend that Americans consume less than 2,300 milligrams of salt daily - 1,500 mg in certain people who are more at risk for high blood pressure or heart disease.

4 May 2011

iOWH, Center for World Health and Medicine partner to combat childhood diarrhea

The Center for World Health and Medicine at Saint Louis University and the Institute for OneWorld Health have established a joint research agreement to develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children under age 5.

4 May 2011

Viewpoints: Dem representatives on health spending; Star Tribune praises IPAB; NY Times on stem cells

When the debate over the fiscal 2012 budget began, the country — or, more accurately, the media — was focused on Rep. Paul Ryan's proposal. Introduced on behalf of the Republican House majority, our colleague's plan puts the interests of wealthy corporations first by slashing Medicare and Medicaid and spending trillions on a new corporate tax cut. Indeed, cutting is all it seems to do. ... That's not a jobs plan — that's an economic death sentence.

4 May 2011

Cynosure first quarter revenues increase 16% to $21.9 million

Cynosure, Inc. today announced financial results for the three months ended March 31, 2011.

3 May 2011

Nile Therapeutics initiates cenderitide Phase I trial in heart failure

Nile Therapeutics, Inc., a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced dosing of the first patient in a Phase I clinical trial investigating the use of subcutaneous cenderitide.

3 May 2011

Brazilian researchers develop hES cell line for therapeutic transplantation

Brazilian researchers, reporting in the current issue of Cell Transplantation, discovered difficulties in establishing a genetically diverse line of human embryonic stem cells to serve the therapeutic stem cell transplantation needs of the diverse ethnic and genetic Brazilian population.

3 May 2011

MEDNAX first quarter revenue increases 15% to $382.3 million

MEDNAX, Inc. today reported earnings per share of 94 cents for the three months ended March 31, 2011, that were driven by strong revenue growth from both acquisitions and same-unit revenue, that led to operating margin expansion.

3 May 2011

National survey reveals severe asthmatics need more treatment options

Today on World Asthma Day 2011, despite decades of progress on the management and control of asthma – more research, better understanding and powerful treatments – millions of people with severe asthma are still living with serious, frequent, life-threatening symptoms.

3 May 2011

Patients with LEP less likely to receive home health care referral

Among children whose parents and other primary caregivers have limited English proficiency, there is an associated increased length of hospital stay and decreased number of home health care referrals for pediatric inpatients with infections requiring long-term antibiotics, according to a report in the May issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

3 May 2011

Busy brain cells can both contribute to and prevent Alzheimer's

Higher levels of cell chatter boost amyloid beta in the brain regions that Alzheimer's hits first, researchers at Washington University School of Medicine in St. Louis report. Amyloid beta is the main ingredient of the plaque lesions that are a hallmark of Alzheimer's.

3 May 2011

New study: Text-heavy labels can reduce acetaminophen overdose

While well known for relieving everyday aches and pains, few realize that when misused, acetaminophen can lead to acute liver failure and even death, often due to accidental overdose by an uninformed consumer. A new small study looked at what's missing in consumer education about acetaminophen and how to overcome those gaps.

3 May 2011

Asthma research on its way to help sufferers

The University of Newcastle is now conducting a nationwide research program to help people with asthma better control their condition. This study will be testing the effectiveness of combining antibiotics with commonly used treatments in asthmatics. This news comes today on the World Asthma Day. Statistics show that commonly prescribed treatments and medications do not relieve the symptoms for about 10 per cent of asthma patients. It's thought about 80% of people with the condition suffer numerous symptoms, yet 80% say they believe they have it under control.

3 May 2011

Sports-specialization can increase risk of injuries in young athletes

Competitive young athletes are under increasing pressure to play only one sport year round, but such specialization could increase the risk of injuries, a Loyola University Health System study has found.

3 May 2011

Helping Babies Breathe focuses on resuscitation in 'The Golden Minute'

A program that teaches health care workers in developing countries basic techniques to resuscitate babies immediately after birth is saving lives, according to a study to be presented Tuesday, May 3, at the Pediatric Academic Societies annual meeting in Denver.

3 May 2011

JPO issues patent to Silence Therapeutics' RNAi technology

Silence Therapeutics plc announces the issuance of patent 4,705,370, titled "Further Novel Forms of Interfering RNA Molecules," by the Japanese Patent Office.

3 May 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for linagliptin to treat type 2 diabetes

Boehringer Ingelheim and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has approved linagliptin tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

3 May 2011

Ipsen first quarter sales increase 6.1% to €285.8 million

Ipsen reported today its sales for the first quarter 2011.

3 May 2011

Beta amyloid may inhibit specific cell motors and contribute to memory loss

A protein associated with Alzheimer's disease clogs several motors of the cell transport machinery critical for normal cell division, leading to defective neurons that may contribute to the memory-robbing disease, University of South Florida researchers report.

3 May 2011

Guided Therapeutics launches LuViva Advanced Cervical Scan

Guided Therapeutics, Inc., unveiled the new name and new industrial design for its non-invasive and painless test for the early detection of cervical precancer.

3 May 2011